selenocysteine has been researched along with Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boucher, KM; Cassidy, JP; Cassidy, PB; Fain, HD; Florell, SR; Gerads, R; Grossman, D; Leachman, SA; Moos, PJ; Tran, SM | 1 |
| Chen, Z; Deng, L; Li, C; Wang, Y; Zhang, X; Zhang, Y | 1 |
| Gangapurkar, B; Jariwalla, RJ; Nakamura, D | 1 |
3 other study(ies) available for selenocysteine and Melanoma
| Article | Year |
|---|---|
Selenium for the prevention of cutaneous melanoma.
Topics: Animals; Cell Cycle; Cell Line, Tumor; Cell Survival; Female; Human Growth Hormone; Humans; Male; Melanoma; Mice; Mice, Transgenic; Organoselenium Compounds; Proportional Hazards Models; RNA; Selenium; Selenocysteine; Skin Neoplasms; Sodium Selenite; Ultraviolet Rays | 2013 |
Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Humans; Liposomes; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Peptides, Cyclic; Polyethylene Glycols; Protein Stability; Random Allocation; Selenocysteine | 2013 |
Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Topics: Adenocarcinoma; Adolescent; Adult; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cysteine; Epithelial Cells; Female; Humans; Liver Neoplasms; Male; Melanoma; Middle Aged; Neoplasms; Neuroectodermal Tumors, Primitive, Peripheral; Organoselenium Compounds; Selenium Compounds; Selenocysteine; Selenomethionine; Skin Neoplasms | 2009 |